Systems and methods for targeted imaging and ablation of cardiac cells
US-2015328315-A1 · Nov 19, 2015 · US
US10617652B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10617652-B2 |
| Application number | US-201515508955-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 17, 2015 |
| Priority date | Sep 17, 2014 |
| Publication date | Apr 14, 2020 |
| Grant date | Apr 14, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides pH- or redox-responsive and charge-neutral polymeric nanogels that stably encapsulate a biomolecule at one pH or redox condition and then release it at a different pH or redox condition, and compositions and methods of preparation and use thereof.
Opening claim text (preview).
The invention claimed is: 1. A crosslinked polymeric nanogel, adapted to stably encapsulate a hydrophilic biomolecule at a first pH condition and then release it at a second pH condition, wherein the crosslinked polymeric nanogel is crosslinked with an acid-labile crosslinker and comprises the structural unit: wherein each of R 1 , R 2 , R 3 R 4 , R 5 and R 6 is independently a hydrogen, C 1 -C 12 alkyl group, or halogen; each of x and y is independently a positive number; each of m and p is independently an integer from about 1 to about 10; n is a positive number from 1 to about 200; and X is independently chosen from O and NH. 2. The crosslinked polymeric nanogel of claim 1 , wherein each of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is a hydrogen. 3. The crosslinked polymeric nanogel of claim 1 , wherein the second pH is lower than the first pH. 4. The crosslinked polymeric nanogel of claim 3 , wherein the second pH is from about 3.5 to about 6.4 and the first pH is from about 6.5 to about 8.0. 5. A crosslinked polymeric nanogel, adapted to stably encapsulate a hydrophilic biomolecule at a first redox condition and then release it at a second redox condition, wherein the crosslinked polymeric nanogel is crosslinked with a redox-labile crosslinker and comprises the structural unit: wherein each of R 1 , R 2 , R 3 R 4 , R 5 and R 6 is independently a hydrogen, C 1 -C 12 alkyl group, or halogen; R 7 is independently a hydrogen, C 1 -C 12 alkyl group, or an ethyleneglycol chain with 2 to about 200 repeat units; each of x and y is independently a positive number; n is a positive number from 1 to about 200; and X is independently chosen from O or NH. 6. The crosslinked polymeric nanogel of claim 5 , wherein each of R 1 , R 2 , R 3 , R 4 , R 5 and R 6 is a hydrogen. 7. The crosslinked polymeric nanogel of claim 5 , wherein the redox-labile crosslinker comprises one or more moieties selected from acrylate, methacrylate or a disulfide moiety.
General methods applicable to biologically active non-coding nucleic acids · CPC title
Antisense · CPC title
Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence) · CPC title
Double-stranded nucleic acids or oligonucleotides · CPC title
Aptamers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.